Action and Spectrum

Drug Interaction

Adverse Reaction

Adverse drug reactions:

Frequency defined 

>10% 

Headache 

Dizziness  

Fatigue  

1-10% 

Edema  

Rhinitis 

Dyspnea  

Nausea 

Abdominal pain  

Vertigo  

Upper respiratory tract infection (URTI) 

Hypotension  

Black Box Warning

Contraindication / Caution

Pregnancy / Lactation

Pregnancy warnings:  

US FDA pregnancy category: Not Assigned

Breastfeeding warnings:

The release of the drug into the human breastmilk is known

Pregnancy Categories:    

Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.

Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women

Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women

Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits

Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.

Category N: There is no data available for the drug under this category

Pharmacology

Adminstartion

Patient Information Leaflet

Patient Information Leaflet

Generic Name: doxazosin

Pronounced: dox-AZE-oh-sin

Why do we use doxazosin?

doxazosin is an anti-hypertensive drug belonging to the subclass alpha-blocker used to treat hypertension. It mainly helps decrease high blood pressure and helps from the risk of heart attacks, strokes, and kidney diseases.